The Approved Premises (Substance Testing) Act 2022 (Commencement) Regulations 2022 No. 1013


BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Statutory Instruments


You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Approved Premises (Substance Testing) Act 2022 (Commencement) Regulations 2022 No. 1013
URL: http://www.bailii.org/uk/legis/num_reg/2022/uksi_20221013_en_1.html

[New search] [Help]


Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Statutory Instruments

2022 No. 1013

Criminal Law, England And Wales

The Approved Premises (Substance Testing) Act 2022 (Commencement) Regulations 2022

Made

28th September 2022

The Secretary of State, in exercise of the power conferred by section 2(2) of the Approved Premises (Substance Testing) Act 2022( 1), makes the following Regulations.

Citation and extent

1.  These Regulations may be cited as the Approved Premises (Substance Testing) Act 2022 (Commencement) Regulations 2022.

2.  These Regulations extend to England and Wales.

Commencement of Act

3.  The Approved Premises (Substance Testing) Act 2022 comes into force on 3rd October 2022.

Rob Butler

Parliamentary Under Secretary of State

Ministry of Justice

28th September 2022

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations commence the whole of the Approved Premises (Substance Testing) Act 2022.

The Approved Premises (Substance Testing) Act 2022 inserts a new section 13A (approved premises: substance testing) into the Offender Management Act 2007 (c. 21)to set out powers to substance and prevalence test residents of approved premises. Under these powers, residents can be required to provide a sample, which will be used to ascertain whether a resident has controlled drugs, prescription medicine, medicinal products, or psychoactive substances in their system.

( 1)

2022 c. 27.


BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/legis/num_reg/2022/uksi_20221013_en_1.html